These opportunities are not managed nor endorsed by RCPCH. Though we do our best to ensure they are relevant and high quality, we cannot take any responsibility for their content or accuracy. If you have questions or would like to submit a joint funding application with the College, contact us on firstname.lastname@example.org.
Funds research into malignant and benign colorectal disease and /or research into Bowel Disease (with a preference for colorectal cancer).
Area of interest is lower GI/ bowel research in malignant and non-malignant, diagnostic or treatment studies or device/intervention development for which future translation to tangible patient benefit can be anticipated.
Intended to enable outstanding graduates to gain the necessary skills and training to set them on course for the development of an independent career in one of their three priority research areas, or to support clinicians entering a clinical academic career pathway focused on one of these areas.
To allow talented students to complete a PhD in cardiovascular science in an established research institution in the UK.
Funding is available to support a PhD student performing research in one or more of the following priority areas: chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), children’s lung disease and bronchiectasis.
To encourage young scientists to gain their PhD whilst researching Inflammatory Bowel Disease.
Funds hands-on experience of research during the academic summer vacation for promising medical and basic science undergraduates.
Enables outstanding science graduates to study for a PhD in the field of diabetes research.
Provides a grant of up to £100,000 to support the training of a graduate student to take up a career in ophthalmic and vision research and leading to the presentation of a PhD.
Supports talented non-clinical post-doctoral researchers to lead their own research plans and establish their own research team to make the transition from post-doctoral researcher to independent investigator.